FDA to Review Long Acting Form of Zyprexa

Zyprexa, the schizophrenia and bipolar drug manufactured by Eli Lilly, is now being considered in an injectable form every two to three weeks. The injection would be administered in a doctor’s office. In spite of the drug’s association with diabetes, the main concern with the longer acting form of the drug is a severe form of sleepiness.